TY - JOUR
T1 - Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program
AU - Frey, P.
AU - Stinson, T.
AU - Siston, A.
AU - Knight, S. J.
AU - Ferdman, E.
AU - Traynor, A.
AU - O'Gara, K.
AU - Rademaker, A.
AU - Bennett, C.
AU - Winter, J. N.
N1 - Funding Information:
This study was supported in part by the Department of Defense, DAMD17-96-2-6013, NIH/NCI P30 CA60553-09, and the NIH/NCRR M01 RR00048.
PY - 2002/12
Y1 - 2002/12
N2 - Our goal was to compare direct and indirect medical costs and quality of life associated with inpatient vs outpatient autologous hematopoietic stem cell transplantation (AuHSCT). Twenty-one sequential outpatients and 26 inpatients were enrolled on this prospective trial. All candidates for AuHSCT were screened for eligibility for outpatient transplantation. Patients with either breast cancer or hematologic malignancy, insurance coverage for the outpatient procedure, one to three caregivers available to provide 24 h coverage, and no significant comorbidities were eligible to participate. Patients without caregivers or insurance coverage for outpatient transplant were accrued to the study in a consecutive manner as inpatient controls, based on willingness to participate in the quality of life portion of the study and to permit review of their hospital and billing records. Approximately half of all 139 prospective outpatient candidates were ineligible because they lacked a caregiver. Most commonly, the patient without a caregiver was single or widowed or their family and friends were needed to provide childcare. Most caregivers were college educated from families with incomes greater than $80 000. Indirect costs to the caregivers totaled a median of $2520 (range $684-$4508), with the majority attributed to lost 'opportunity costs'. Overall, there were significant differences in the total costs of treatment for inpatient vs outpatient AuHSCT ($40 985 vs $29 210, P < 0.01)). In general, no significant differences were detected between inpatient and outpatient scores on quality of life measures. Although significant cost savings were associated with outpatient transplantation, this approach was applicable to only half of our otherwise eligible candidates because of a lack of caregivers. The financial burden associated with the caretaking role may underlie this finding.
AB - Our goal was to compare direct and indirect medical costs and quality of life associated with inpatient vs outpatient autologous hematopoietic stem cell transplantation (AuHSCT). Twenty-one sequential outpatients and 26 inpatients were enrolled on this prospective trial. All candidates for AuHSCT were screened for eligibility for outpatient transplantation. Patients with either breast cancer or hematologic malignancy, insurance coverage for the outpatient procedure, one to three caregivers available to provide 24 h coverage, and no significant comorbidities were eligible to participate. Patients without caregivers or insurance coverage for outpatient transplant were accrued to the study in a consecutive manner as inpatient controls, based on willingness to participate in the quality of life portion of the study and to permit review of their hospital and billing records. Approximately half of all 139 prospective outpatient candidates were ineligible because they lacked a caregiver. Most commonly, the patient without a caregiver was single or widowed or their family and friends were needed to provide childcare. Most caregivers were college educated from families with incomes greater than $80 000. Indirect costs to the caregivers totaled a median of $2520 (range $684-$4508), with the majority attributed to lost 'opportunity costs'. Overall, there were significant differences in the total costs of treatment for inpatient vs outpatient AuHSCT ($40 985 vs $29 210, P < 0.01)). In general, no significant differences were detected between inpatient and outpatient scores on quality of life measures. Although significant cost savings were associated with outpatient transplantation, this approach was applicable to only half of our otherwise eligible candidates because of a lack of caregivers. The financial burden associated with the caretaking role may underlie this finding.
KW - Caregivers
KW - Healthcare economics
KW - Outpatient transplantation
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=0036905475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036905475&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1703676
DO - 10.1038/sj.bmt.1703676
M3 - Article
C2 - 12439696
AN - SCOPUS:0036905475
SN - 0268-3369
VL - 30
SP - 741
EP - 748
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 11
ER -